Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Melatonin on Tourniquet-Induced Ischemia–Reperfusion Injury in Lower Extremity Orthopedic Surgery
IRCT20141009019470N87Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in ischemia-reperfusion injury (IRI), sponsored by Shiraz University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
melatonin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on IRCT20141009019470N87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N87.